Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
CMS Publishes Initial Guidance Documents For Inflation Rebate Provisions
On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents (Part B and…
California Sues Six Companies Over Insulin Pricing
California Attorney General Rob Bonta filed a lawsuit against six companies that dominate the United States insulin market,…
Brand-Name Prescription Drug Prices Continue to Fall
In 2022, brand-name prescription drug prices fell for the fifth consecutive year, despite media coverage to the contrary. Even…
ICER Releases Unsupported Price Increases Report for 2021
Recently, the Institute for Clinical and Economic Review (ICER) published its Unsupported Price Increase Report of prescription…
Biden Administration Seeking Input on Lowering Drug Prices
On October 14, President Biden issued an Executive Order (EO) calling for new payment and delivery models that will lower drug…
HHS Report Finds More than 1200 Drugs Raised Prices Quicker than Inflation…
A recent report published by the United States Department of Health and Human Services (HHS) found that more than 1,200…
CBO Gives Congress Advice on How to Battle Rising Commercial Health Insurer…
In September 2022, the Congressional Budget Office (CBO) released a new report, Policy Approaches to Reduce What Commercial…
Biden Issues Executive Order on Drug Prices
On October 14, 2022, United States President Joe Biden issued an Executive Order on Lowering Prescription Drug Costs for…
HHS OIG Finds that Eight Drug Codes Met CMS’ Price Substitution Criteria
Earlier this year, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) conducted a…
Policy and Medicine Compliance Update August 2022 Issue: Focus on 340B…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…